Search Results
Sep 19, 2025, 07:13 ET FDA Grants Orphan Drug Designation to NS-051/NCNP-04 for the Treatment of Duchenne Muscular Dystrophy
cause Duchenne, and NS-051/NCNP-04 is being developed to treat patients with confirmed gene mutations amenable to exon 51 skipping therapy. NS-051/NCNP-04 is an antisense oligonucleotide co-discovered by the National Center of Neurology and Psychiatry (NCNP) and Nippon Shinyaku. NS-051/NCNP-04 promotes
More news about: NS Pharma, Inc.
Sep 18, 2025, 08:45 ET Nektar Presents New Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin in Late-Breaker Oral Presentation at EADV 2025
18% ns 17% ns
More news about: Nektar Therapeutics
Sep 18, 2025, 01:05 ET 《第十三屆微電影「創+作」支援計劃（音樂篇）》配對會暨微電影製作啓動禮匯聚跨界創意力量 打造本地影視音樂產業新機遇
15 NS Production 導演: 沈偉彥
More news about: 香港互動市務商會
Sep 15, 2025, 09:00 ET Refreshed ACE Sets New Standard in Life Insurance Digital Applications
ratings, visit pennmutual.com. © 2025 The Penn Mutual Life Insurance Company, Philadelphia, PA 8357189NS_SEP27 Contact: Brittany White Enterprise Communications Manager Penn Mutual 215-956-8378
More news about: The Penn Mutual Life Insurance Company
Sep 11, 2025, 07:16 ET Precision BioLogic lidera las pruebas de hemofilia
una utilidad ampliada en previsión de tratamientos emergentes HALIFAX, NS, 11 de septiembre de 2025 /PRNewswire/ --
More news about: Precision BioLogic